Role of interferon α in promoting T helper cell type 1 responses in the small intestine in coeliac disease

被引:97
作者
Monteleone, G
Pender, SLF
Alstead, E
Hauer, AC
Lionetti, P
MacDonald, TT
机构
[1] Univ Southampton, Sch Med, Southampton Gen Hosp, Div Infect Allergy Inflammat & Repair, Southampton SO16 6YD, Hants, England
[2] St Bartholomews & Royal Sch Med & Dent, Digest Dis Res Ctr, London, England
[3] Graz Univ, Klin Kinder & Jugenheilkunde, Graz, Austria
[4] Univ Florence, Dipartimento Pediat, Florence, Italy
关键词
coeliac disease; interferon; small intestine; T helper cell response;
D O I
10.1136/gut.48.3.425
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Coeliac disease (CD) is caused by a CD4 T helper cell type 1 (Th1) response in the small intestinal mucosa to dietary gluten. As the major Th1 inducing cytokine, interleukin 12, is undetectable in CD gut mucosa, the mechanism by which Th1 effector cells are generated remains unknown. Interferon (IFN) alpha, a cytokine capable of promoting IFN-gamma synthesis, has been implicated in the development of Th1 mediated immune diseases. Here we report a case of CD-like enteropathy in a patient receiving IFN-alpha for chronic myeloid leukaemia, Morphological assessment of duodenal biopsies taken from the patient showed total villous atrophy, crypt cell. hyperplasia, and a high number of CD3(+) intraepithelial lymphocytes. Both antigliadin antibodies and antiendomysial antibodies were positive. RNA analysis revealed pronounced expression of IFN-gamma. Withdrawal of gluten from the diet resulted in a patchy improvement in intestinal morphology, normalisation of laboratory parameters, and resolution of clinical symptoms. By western blot analysis, IFN-alpha protein was seen in the duodenal mucosa from untreated CD patients but not in controls. This was associated with marked expression of IFN-gamma protein in CD mucosa. Collectively, these results suggest a role for IFN-alpha in promoting Th1 responses to gluten.
引用
收藏
页码:425 / 429
页数:5
相关论文
共 29 条
[1]   Interactions between stromal cell-derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia [J].
Bajaj-Elliott, M ;
Poulsom, R ;
Pender, SLF ;
Wathen, NC ;
MacDonald, TT .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (08) :1473-1480
[2]   Celiac disease during interferon treatment [J].
Bardella, MT ;
Marino, R ;
Meroni, PL .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (02) :157-158
[3]   INTERLEUKIN-2 AND INTERFERON-GAMMA PRODUCING CELLS IN THE LAMINA PROPRIA IN CELIAC-DISEASE [J].
BREESE, EJ ;
KUMAR, P ;
FARTHING, MJ ;
MACDONALD, TT .
DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (10) :2243-2243
[4]   Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosis [J].
Brod, SA ;
Kerman, RH ;
Nelson, LD ;
Marshall, GD ;
Henninger, EM ;
Khan, M ;
Jin, R ;
Wolinsky, JS .
MULTIPLE SCLEROSIS JOURNAL, 1997, 3 (01) :1-7
[5]  
Chakrabarti D, 1996, J IMMUNOL, V157, P522
[6]   Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes - A potential role for the acidic sphingomyelinase pathway in normal immunoregulation [J].
DeMaria, R ;
Boirivant, M ;
Cifone, MG ;
Roncaioli, P ;
Hahne, M ;
Tschopp, J ;
Pallone, F ;
Santoni, A ;
Testi, R .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) :316-322
[7]   DEVELOPMENT OF TYPE-1 DIABETES-MELLITUS DURING INTERFERON-ALFA THERAPY FOR CHRONIC HCV HEPATITIS [J].
FABRIS, P ;
BETTERLE, C ;
FLOREANI, A ;
GREGGIO, NA ;
DELAZZARI, F ;
NACCARATO, R ;
CHIARAMONTE, M .
LANCET, 1992, 340 (8818) :548-548
[8]   Inflammatory bowel disease: Etiology and pathogenesis [J].
Fiocchi, C .
GASTROENTEROLOGY, 1998, 115 (01) :182-205
[9]   The pathogenesis of celiac disease [J].
Godkin, A ;
Jewell, D .
GASTROENTEROLOGY, 1998, 115 (01) :206-210
[10]   CYTOKINE THERAPEUTICS - LESSONS FROM INTERFERON-ALPHA [J].
GUTTERMAN, JU .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) :1198-1205